Delivery Order SPE2DB24D2205-SPE2DB25FEFXG
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $99,607.10 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used to treat overactive bladder, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,747.33 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used to treat overactive bladder symptoms,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $8,109.88. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,880.45 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract is executed as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,344.44 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This competitive delivery order is structured as a firm fixed price contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used in the treatment of overactive bladder,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,679.22. The award, issued on July 3, 2025, with an ultimate completion date of July 7, 2025, represents a non-competitive procurement leveraging the company's existing contract vehicle. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,300.99 for 90-tablet bottles of Gemtesa 75 mg on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used to treat overactive bladder, representing a component of the...
- The Defense Logistics Agency awarded a delivery order valued at $11,889.17 to AmerisourceBergen Drug Corp for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its Corporate Office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,657.38 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, a medication used to treat overactive bladder. The contract was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $32,547.85 to AmerisourceBergen Drug Corp for 90-count tablets of Gemtesa 75 mg on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a pharmaceutical product used in the treatment of overactive bladder, representing one...